Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases
Observational study · 1991
- What was studied
- 21 patients with neuromuscular diseases
- Main finding
- Examined lipid peroxidation and erythrocyte-membrane permeability during Bemitil treatment.
Reported findings and study design
21 patients with neuromuscular diseases; lipid peroxidation and erythrocyte membrane permeability measured.
Population or model 21 patients with neuromuscular diseases
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Metabolic and membrane measurements | Changes reported | Magnitude, dose and comparator results not quantified in the abstract |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Clinical-trial indexing does not establish randomization or a concurrent control.
- Biochemical changes do not establish durable functional improvement.
- Possible cohort overlap with the 1992 report needs full-text checking.
Source details
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Sources checked
Citation
V. S. Lobzin, L. A. Saikova, M. L. Chukhlovina, V. G. Pustozerov. Mechanisms of the therapeutic effect of Bemitil in neuromuscular diseases Zh Nevropatol Psikhiatr Im S S Korsakova. 91(9):22–24. PMID 1664607